Some Amazing Research Going on To Enhance Fertility:

With all the technological developments that take place regularly in other industries, it is exciting to see some major advancements being made in the R&D departments of companies focused on reproductive health.

OvaScience™- R&D on AUGMENT, a product that “allows the woman to use her own cellular energy to revitalize the egg”. The company just recently closed on a $37 Million “Series-B” round of funding.

Auxogyn™- A company focusing on improving early embryo viability with their cutting edge software. Read all about their exciting progress on their webpage:

Celmatix™- Focuses on diagnostic tools to improve reproductive health. The company raised an additional $1.5 Million in funding in March 2012,

Ib2C™- (Us!!)  Secured $4.5 Million in “Series-A” funding in December 2011. Intimate Bridge to Conception, Inc. (Ib2C™) is an early-stage direct to consumer medical device company focused on reproductive health to aid in natural fertility and conception in the privacy of the patient’s home.

I don’t know about you, but it looks to me like the future R&D in our reproductive health is looking bright.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s